Similar articles

• [Thrombocyte aggregation inhibitors, anticoagulants and thrombolytic agents in heart diseases].

  Darius H, Erbel R, Belz GG, Meyer J. Darius H, et al. Internist (Berl). 1992 Oct;33(10):670-83. Internist (Berl). 1992. PMID: 1428685 Review. German. No abstract available.
• Thromboembolic events in pregnancy: pharmacological prophylaxis and treatment.

  Nelson SM, Greer IA. Nelson SM, et al. Expert Opin Pharmacother. 2007 Dec;8(17):2917-31. doi: 10.1517/14656566.8.17.2917. Expert Opin Pharmacother. 2007. PMID: 18001253 Review.
• [Antithrombotic therapy in acute coronary syndrome].

  Chazov EI, Panchenko EP. Chazov EI, et al. Ter Arkh. 2000;72(3):65-75. Ter Arkh. 2000. PMID: 10776658 Review. Russian. No abstract available.
• Novel Antithrombotic Drugs on the Horizon: The Ultimate Promise to Prevent Clotting While Avoiding Bleeding.

  McFadyen JD, Peter K. McFadyen JD, et al. Circ Res. 2017 Oct 27;121(10):1133-1135. doi: 10.1161/CIRCRESAHA.117.312012. Circ Res. 2017. PMID: 29074533 Review. No abstract available.
• Future Antithrombotic Therapies in Cardiology.

  Bäuml M, Hilgendorf I. Bäuml M, et al. Hamostaseologie. 2018 Nov;38(4):236-239. doi: 10.1055/s-0038-1670653. Epub 2018 Sep 28. Hamostaseologie. 2018. PMID: 30267387 Review.